Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04469803 · ClinicalTrials.gov registry record · NA

Impact of Intra-Shift Napping on EMS Cardiovascular Health

A NA study of Blood Pressure and Heart Rate Variability, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT04469803: Completed NA study of Blood Pressure and Heart Rate Variability, sponsored by University of Pittsburgh.

NCT04469803 is a NA study of Blood Pressure and Heart Rate Variability that has completed, run by University of Pittsburgh. The registered enrollment target is 28 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04469803, a NA study of Blood Pressure and Heart Rate Variability, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

Cardiovascular disease (CVD) exerts a significant health burden among shift workers, including police, firefighters, and emergency medical services (EMS). The unique occupational demands inherent to these professions--sleep loss, circadian misalignment, high stress, and sustained hyper-vigilance--confer increased risk for both on and off-duty cardiovascular events. Mitigating cardiovascular risks in these professions requires that we first identify robust markers and potential mechanisms of risk. Previous work suggest shift work has a negative impact on blood pressure (BP) and heart rate variability (HRV). Blunted BP dipping at night and during sleep, and reduced HRV are powerful markers of increased CVD risk. Both are linked to preclinical indicators of cardiac damage, such as presence of coronary artery calcium, left atrial enlargement, and cardiovascular-related mortality. This study will use an experimental crossover study design with three intervention conditions to test the impact of a 30 minute brief nap and a 2-hour longer nap versus no nap on BP and HRV. Outcomes of interest include blunted dipping of BP during nighttime hours and during sleep and HRV.

Primary Outcome

Blood pressure is created by the heart muscle contractions and is measured using two numbers: The Systolic Blood Pressure (SBP) and the Diastolic Blood Pressure (DBP). Normal patterns in BP include elevations in SBP and DBP during the daylight and waking hours followed by a drop (dip) during nighttime hours and during sleep. A dip of 10% to 20% during nighttime or sleep is considered normal, whereas a dip \<10% is defined as blunted BP dipping. Blunted BP dipping will be quantified as: \[(mean B

Interventions

  • BEHAVIORAL Intra-Shift Napping

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2021-03-01
Est. Completion 2022-10-02
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT04469803 record still lists

NCT04469803 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (90% lower).

The record links to 2 conditions, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Intra-Shift Napping is the first listed.

NCT04469803 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04469803 about?

NCT04469803 is a clinical study titled "Impact of Intra-Shift Napping on EMS Cardiovascular Health". Cardiovascular disease (CVD) exerts a significant health burden among shift workers, including police, firefighters, and emergency medical services (EMS). The unique occupational demands inherent to these professions--sleep loss, circadian misalignment, high stress, and sustained hyper-vigilance--co...

What is the current status of trial NCT04469803?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2021-03-01. Estimated completion is 2022-10-02.

What conditions does trial NCT04469803 study?

This clinical trial studies the following conditions: Blood Pressure, Heart Rate Variability.

What interventions are being tested in trial NCT04469803?

The interventions under investigation include: Intra-Shift Napping (BEHAVIORAL).

Who is sponsoring clinical trial NCT04469803?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04469803 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04469803's enrollment target sits among peer trials

28 82nd of 101 higher than 20 of 101 other Blood Pressure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04469803, the US trial registry maintained by the National Library of Medicine. NCT04469803 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.